Mangalam Drugs And Organics Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue increased from ₹76.54 Crore to ₹79.94 Crore in the latest quarter.
Operating profit margin improved to 1.06%, reflecting better cost management.
EPS remained positive at ₹1.70 in the last quarter, indicating resilience despite challenges.

NEGATIVES

Net profit dropped to ₹-13.80 Crore in the latest quarter, signaling severe financial strain.
Revenue decreased significantly from ₹102.24 Crore to ₹76.54 Crore in just three months.
High material costs remain a concern, averaging around 51.28% in the latest quarter.

Field	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	97.34	102.24	76.54	79.94	88.71	73.04	57.35
Expenses	97.30	98.35	75.97	78.88	87.48	71.61	70.35
Operating Profit	0.04	3.88	0.56	1.06	1.23	1.42	-13
Other Income	0	0.05	0.02	0.14	0.14	0.21	0
Interest	3.31	3.95	3.75	3.67	3.49	4.03	4.04
Depreciation	3.63	3.86	3.88	3.98	4.05	4.70	4.48
Profit Before Tax	0.04	3.93	0.58	1.20	1.37	1.63	-13
Tax	-0.46	0.40	-2.10	-1.49	0.08	1.57	0.80
Net Profit	0.50	3.53	2.69	2.69	1.29	0.06	-13.80
Eps in Rs	0.31	2.23	1.70	1.70	0.81	0.04	-8.72